CA2365728A1 - Vaccin antiviral attenue du dengue de type 1 - Google Patents
Vaccin antiviral attenue du dengue de type 1 Download PDFInfo
- Publication number
- CA2365728A1 CA2365728A1 CA 2365728 CA2365728A CA2365728A1 CA 2365728 A1 CA2365728 A1 CA 2365728A1 CA 2365728 CA2365728 CA 2365728 CA 2365728 A CA2365728 A CA 2365728A CA 2365728 A1 CA2365728 A1 CA 2365728A1
- Authority
- CA
- Canada
- Prior art keywords
- virus
- dengue
- vaccine
- cells
- attenuated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
La présente invention concerne des compositions de vaccin antiviral atténué du dengue de type 1. Plus spécifiquement, le virus atténué est produit par un passage en série dans des cellules PDK. L'invention concerne également des méthodes de stimulation du système immunitaire d'un individu afin d'induire une protection contre le virus du dengue de type 1 par administration du virus atténué du dengue de type 1.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12631799P | 1999-03-26 | 1999-03-26 | |
US60/126,317 | 1999-03-26 | ||
US18206400P | 2000-02-11 | 2000-02-11 | |
US60/182,064 | 2000-02-11 | ||
PCT/US2000/008201 WO2000057908A2 (fr) | 1999-03-26 | 2000-03-24 | Vaccin antiviral attenue du dengue de type 1 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2365728A1 true CA2365728A1 (fr) | 2000-10-05 |
Family
ID=26824511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2365728 Abandoned CA2365728A1 (fr) | 1999-03-26 | 2000-03-24 | Vaccin antiviral attenue du dengue de type 1 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1165131A2 (fr) |
JP (1) | JP2002540169A (fr) |
AU (1) | AU4179200A (fr) |
CA (1) | CA2365728A1 (fr) |
WO (1) | WO2000057908A2 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2906724B1 (fr) | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | Methode d'immunisation contre les 4 serotypes de la dengue. |
KR101695800B1 (ko) | 2008-03-05 | 2017-02-22 | 사노피 파스퇴르 | 항원보강제 함유 백신 조성물의 안정화 방법 |
EP2143440A1 (fr) | 2008-07-09 | 2010-01-13 | Sanofi Pasteur | Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués |
EP2353609A1 (fr) | 2010-02-04 | 2011-08-10 | Sanofi Pasteur | Compositions et procédés d'immunisation |
KR20200067938A (ko) | 2012-07-24 | 2020-06-12 | 사노피 파스퇴르 | 백신 조성물 |
MX2015000446A (es) | 2012-07-24 | 2015-03-12 | Sanofi Pasteur | Composiciones de vacuna para la prevencion contra la infeccion por el virus del dengue. |
WO2014083194A1 (fr) | 2012-11-30 | 2014-06-05 | Sanofi Pasteur | Procédés d'induction d'anticorps |
KR20160023683A (ko) | 2013-06-21 | 2016-03-03 | 머크 샤프 앤드 돔 코포레이션 | 뎅기 바이러스 백신 조성물 및 그의 사용 방법 |
WO2016106107A2 (fr) | 2014-12-22 | 2016-06-30 | Merck Sharp & Dohme Corp. | Compositions de vaccin contre le virus de la dengue et procédés pour les utiliser |
BE1024160A9 (fr) | 2015-12-22 | 2017-12-06 | Glaxosmithkline Biologicals Sa | Formulation immunogène |
WO2019069130A1 (fr) | 2017-10-05 | 2019-04-11 | Sanofi Pasteur | Compositions pour vaccination de rappel contre la dengue |
-
2000
- 2000-03-24 CA CA 2365728 patent/CA2365728A1/fr not_active Abandoned
- 2000-03-24 AU AU41792/00A patent/AU4179200A/en not_active Abandoned
- 2000-03-24 WO PCT/US2000/008201 patent/WO2000057908A2/fr not_active Application Discontinuation
- 2000-03-24 EP EP20000921482 patent/EP1165131A2/fr not_active Withdrawn
- 2000-03-24 JP JP2000607658A patent/JP2002540169A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1165131A2 (fr) | 2002-01-02 |
WO2000057908A9 (fr) | 2001-10-11 |
JP2002540169A (ja) | 2002-11-26 |
WO2000057908A3 (fr) | 2001-01-25 |
AU4179200A (en) | 2000-10-16 |
WO2000057908A2 (fr) | 2000-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6638514B1 (en) | Multivalent dengue virus vaccine | |
AU2007327367B2 (en) | Immunization protocol against the 4 dengue serotypes | |
US6537557B1 (en) | Attenuated dengue-4 virus vaccine | |
US6511667B1 (en) | Attenuated dengue-2 virus vaccine | |
CA2365728A1 (fr) | Vaccin antiviral attenue du dengue de type 1 | |
US6528065B1 (en) | Attenuated dengue-3 virus vaccine | |
AU776638B2 (en) | Adaptation of virus to vertebrate cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |